loading
Schlusskurs vom Vortag:
$11.31
Offen:
$11.41
24-Stunden-Volumen:
188.19K
Relative Volume:
0.93
Marktkapitalisierung:
$441.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.60%
1M Leistung:
+25.53%
6M Leistung:
-35.83%
1J Leistung:
-52.82%
1-Tages-Spanne:
Value
$11.19
$12.17
1-Wochen-Bereich:
Value
$11.05
$12.26
52-Wochen-Spanne:
Value
$7.13
$29.74

Rapport Therapeutics Inc Stock (RAPP) Company Profile

Name
Firmenname
Rapport Therapeutics Inc
Name
Telefon
857-321-8020
Name
Adresse
1325 BOYLSTON STREET, BOSTON
Name
Mitarbeiter
69
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
RAPP's Discussions on Twitter

Vergleichen Sie RAPP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RAPP
Rapport Therapeutics Inc
11.80 441.62M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-08 Eingeleitet Citizens JMP Mkt Outperform
2024-07-02 Eingeleitet Jefferies Buy
2024-07-02 Eingeleitet Stifel Buy
2024-07-02 Eingeleitet TD Cowen Buy

Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten

pulisher
Jun 17, 2025

GAMMA Investing LLC Purchases 9,198 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 17, 2025
pulisher
Jun 17, 2025

Bank of America Corp DE Sells 12,532 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 17, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Purchases 7,886 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Analysts Can't Get Enough of These Little-Known Biopharma Stocks - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Analysts Can't Get Enough of These Little-Known Biopharma Stocks - MarketBeat

Jun 12, 2025
pulisher
Jun 09, 2025

(RAPP) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 09, 2025
pulisher
Jun 05, 2025

Rapport Therapeutics management to meet with Citizens JMP - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Deutsche Bank AG Invests $41,000 in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Analysts Offer Insights on NA Companies: Tempus AI, Inc. Class A (TEM) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail

Jun 04, 2025
pulisher
Jun 03, 2025

Stifel reiterates buy rating for Rapport Therapeutics stock By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Citizens JMP maintains positive outlook on Rapport Therapeutics stock By Investing.com - Investing.com UK

Jun 03, 2025
pulisher
Jun 02, 2025

Rapport Therapeutics Completes Enrollment for Phase 2a Trial - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Rapport Therapeutics Hosts Inaugural Investor and Analyst Day to Update on RAP-219 and Clinical Pipeline - Nasdaq

Jun 02, 2025
pulisher
May 28, 2025

How the (RAPP) price action is used to our Advantage - news.stocktradersdaily.com

May 28, 2025
pulisher
May 27, 2025

Rapport Therapeutics to Participate in the Jefferies Global - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference - Yahoo Finance

May 27, 2025
pulisher
May 26, 2025

Rapport Therapeutics (RAPP) to Release Quarterly Earnings on Monday - Defense World

May 26, 2025
pulisher
May 21, 2025

Rapport Therapeutics to Host 2025 Investor and Analyst Day - GlobeNewswire

May 21, 2025
pulisher
May 16, 2025

Companies Like Rapport Therapeutics (NASDAQ:RAPP) Are In A Position To Invest In Growth - Yahoo Finance

May 16, 2025
pulisher
May 14, 2025

Rapport Therapeutics Reports Q1 2025 Financial Results - MSN

May 14, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Grows Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

May 13, 2025
pulisher
May 11, 2025

Barclays PLC Buys 5,634 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

May 11, 2025
pulisher
May 08, 2025

Rapport Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update - The Manila Times

May 08, 2025
pulisher
May 07, 2025

(RAPP) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 07, 2025
pulisher
May 06, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 06, 2025
pulisher
May 02, 2025

Legal & General Group Plc Buys 8,614 Shares of Rapport Therapeutics (NASDAQ:RAPP) - Defense World

May 02, 2025
pulisher
Apr 28, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 28, 2025
pulisher
Apr 22, 2025

Rapport Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

When the Price of (RAPP) Talks, People Listen - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 17, 2025

Rapport therapeutics chief scientific officer sells $81,310 of stock - Investing.com Australia

Apr 17, 2025
pulisher
Apr 16, 2025

Rapport therapeutics chief scientific officer sells $81,310 of stock By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 13, 2025

KLP Kapitalforvaltning AS Purchases Shares of 1,900 Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

48,452 Shares in Rapport Therapeutics (NASDAQ:RAPP) Acquired by Norges Bank - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Comparing Rapport Therapeutics (RAPP) & The Competition - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated at JMP Securities - Defense World

Apr 10, 2025
pulisher
Apr 08, 2025

JMP Securities Initiates Coverage of Rapport Therapeutics (RAPP) with Market Outperform Recommendation - Nasdaq

Apr 08, 2025
pulisher
Apr 08, 2025

Citizens JMP sets $28 target for Rapport Therapeutics stock By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 05, 2025

(RAPP) Investment Analysis - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 02, 2025

nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
pulisher
Mar 31, 2025

Rapport Therapeutics: Too Early To Be Interesting (NASDAQ:RAPP) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Swiss National Bank Purchases New Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 31, 2025
pulisher
Mar 27, 2025

Analyzing Neurogene (NASDAQ:NGNE) & Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 26, 2025
pulisher
Mar 25, 2025

Validea Kenneth Fisher Strategy Daily Upgrade Report3/25/2025 - Nasdaq

Mar 25, 2025

Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)

Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):